
Company Number
IE416220
Next Accounts
May 2025
Shareholders
garden city pharmacy limited
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
unit 4, garden city shopping centre, ashbourne co meath, ashbourne meath ireland, 23604
Website
-Pomanda estimates the enterprise value of ASHBOURNE PHARMACY LIMITED at €387.9k based on a Turnover of €1.1m and 0.35x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ASHBOURNE PHARMACY LIMITED at €735.7k based on an EBITDA of €191.9k and a 3.83x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ASHBOURNE PHARMACY LIMITED at €2.2m based on Net Assets of €1.1m and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ashbourne Pharmacy Limited is a live company located in ashbourne co meath, 23604 with a Companies House number of IE416220. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in March 2006, it's largest shareholder is garden city pharmacy limited with a 100% stake. Ashbourne Pharmacy Limited is a established, small sized company, Pomanda has estimated its turnover at €1.1m with high growth in recent years.
Pomanda's financial health check has awarded Ashbourne Pharmacy Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
6 Weak
Size
annual sales of €1.1m, make it smaller than the average company (€11.9m)
- Ashbourne Pharmacy Limited
€11.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 19%, show it is growing at a faster rate (6.6%)
- Ashbourne Pharmacy Limited
6.6% - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
- Ashbourne Pharmacy Limited
32.4% - Industry AVG
Profitability
an operating margin of 16.6% make it more profitable than the average company (3.1%)
- Ashbourne Pharmacy Limited
3.1% - Industry AVG
Employees
with 10 employees, this is below the industry average (73)
10 - Ashbourne Pharmacy Limited
73 - Industry AVG
Pay Structure
on an average salary of €25.6k, the company has an equivalent pay structure (€25.6k)
- Ashbourne Pharmacy Limited
€25.6k - Industry AVG
Efficiency
resulting in sales per employee of €111.7k, this is less efficient (€144.4k)
- Ashbourne Pharmacy Limited
€144.4k - Industry AVG
Debtor Days
it gets paid by customers after 38 days, this is later than average (30 days)
- Ashbourne Pharmacy Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 32 days, this is quicker than average (65 days)
- Ashbourne Pharmacy Limited
65 days - Industry AVG
Stock Days
it holds stock equivalent to 48 days, this is more than average (36 days)
- Ashbourne Pharmacy Limited
36 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 336 weeks, this is more cash available to meet short term requirements (14 weeks)
336 weeks - Ashbourne Pharmacy Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 10.3%, this is a lower level of debt than the average (58.3%)
10.3% - Ashbourne Pharmacy Limited
58.3% - Industry AVG
Ashbourne Pharmacy Limited's latest turnover from June 2023 is estimated at €1.1 million and the company has net assets of €1.1 million. According to their latest financial statements, Ashbourne Pharmacy Limited has 10 employees and maintains cash reserves of €834.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|
Turnover | ||||||||
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | ||||||||
Tax | ||||||||
Profit After Tax | ||||||||
Dividends Paid | ||||||||
Retained Profit | ||||||||
Employee Costs | 246,069 | |||||||
Number Of Employees | 10 | 9 | 8 | 7 | 7 | 7 | 8 | 8 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 5,386 | 10,971 | 16,606 | 21,186 | 8,400 | 1,345 | 2,768 | 863 |
Intangible Assets | ||||||||
Investments & Other | ||||||||
Debtors (Due After 1 year) | ||||||||
Total Fixed Assets | 5,386 | 10,971 | 16,606 | 21,186 | 8,400 | 1,345 | 2,768 | 863 |
Stock & work in progress | 100,326 | 91,221 | 91,925 | 96,425 | 81,263 | 80,771 | 80,167 | 87,000 |
Trade Debtors | 116,931 | 45,391 | 51,553 | 40,260 | 33,514 | 25,681 | 28,210 | 29,476 |
Group Debtors | 165,000 | |||||||
Misc Debtors | 197,787 | 192,558 | 208,451 | 201,125 | 198,571 | 194,028 | 36,527 | 22,334 |
Cash | 834,826 | 764,827 | 556,442 | 394,733 | 273,162 | 182,207 | 121,445 | 236,398 |
misc current assets | ||||||||
total current assets | 1,249,870 | 1,093,997 | 908,371 | 732,543 | 586,510 | 482,687 | 431,349 | 375,208 |
total assets | 1,255,256 | 1,104,968 | 924,977 | 753,729 | 594,910 | 484,032 | 434,117 | 376,071 |
Bank overdraft | ||||||||
Bank loan | ||||||||
Trade Creditors | 67,087 | 59,051 | 57,798 | 60,977 | 58,305 | 41,416 | 79,012 | 87,947 |
Group/Directors Accounts | ||||||||
other short term finances | 927 | 758 | ||||||
hp & lease commitments | ||||||||
other current liabilities | 60,897 | 86,089 | 79,739 | 54,062 | 43,405 | 46,798 | 50,370 | 40,830 |
total current liabilities | 128,911 | 145,140 | 138,295 | 115,039 | 101,710 | 88,214 | 129,382 | 128,777 |
loans | ||||||||
hp & lease commitments | ||||||||
Accruals and Deferred Income | ||||||||
other liabilities | ||||||||
provisions | ||||||||
total long term liabilities | ||||||||
total liabilities | 128,911 | 145,140 | 138,295 | 115,039 | 101,710 | 88,214 | 129,382 | 128,777 |
net assets | 1,126,345 | 959,828 | 786,682 | 638,690 | 493,200 | 395,818 | 304,735 | 247,294 |
total shareholders funds | 1,126,345 | 959,828 | 786,682 | 638,690 | 493,200 | 395,818 | 304,735 | 247,294 |
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | 6,810 | 6,395 | 6,243 | 5,822 | 3,445 | 1,423 | 2,170 | |
Amortisation | ||||||||
Tax | ||||||||
Stock | 9,105 | -704 | -4,500 | 15,162 | 492 | 604 | -6,833 | 87,000 |
Debtors | 76,769 | -22,055 | 18,619 | 9,300 | 12,376 | -10,028 | 177,927 | 51,810 |
Creditors | 8,036 | 1,253 | -3,179 | 2,672 | 16,889 | -37,596 | -8,935 | 87,947 |
Accruals and Deferred Income | -25,192 | 6,350 | 25,677 | 10,657 | -3,393 | -3,572 | 9,540 | 40,830 |
Deferred Taxes & Provisions | ||||||||
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | ||||||||
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | ||||||||
Group/Directors Accounts | ||||||||
Other Short Term Loans | 927 | -758 | 758 | |||||
Long term loans | ||||||||
Hire Purchase and Lease Commitments | ||||||||
other long term liabilities | ||||||||
share issue | ||||||||
interest | ||||||||
cash flow from financing | ||||||||
cash and cash equivalents | ||||||||
cash | 69,999 | 208,385 | 161,709 | 121,571 | 90,955 | 60,762 | -114,953 | 236,398 |
overdraft | ||||||||
change in cash | 69,999 | 208,385 | 161,709 | 121,571 | 90,955 | 60,762 | -114,953 | 236,398 |
Perform a competitor analysis for ashbourne pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in Region Area area or any other competitors across 12 key performance metrics.
ASHBOURNE PHARMACY LIMITED group structure
Ashbourne Pharmacy Limited has no subsidiary companies.
Ultimate parent company
ASHBOURNE PHARMACY LIMITED
IE416220
Ashbourne Pharmacy Limited currently has 4 directors. The longest serving directors include BARRY O' DONNELL (Mar 2006) and HELEN O'BRIEN (Feb 2013).
officer | country | age | start | end | role |
---|---|---|---|---|---|
BARRY O' DONNELL | 46 years | Mar 2006 | - | Director | |
HELEN O'BRIEN | 58 years | Feb 2013 | - | Director | |
GARRETT ROSS | 43 years | Nov 2023 | - | Director | |
NIALL DUGGAN | 50 years | Nov 2023 | - | Director |
P&L
June 2023turnover
1.1m
+37%
operating profit
185.1k
0%
gross margin
32.4%
-3.59%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
1.1m
+0.17%
total assets
1.3m
+0.14%
cash
834.8k
+0.09%
net assets
Total assets minus all liabilities
Similar Companies
company number
IE416220
Type
LTD - PRIVATE COMPANY LIMITED BY SHARES
industry
47730 - Dispensing chemist in specialised stores
incorporation date
March 2006
age
19
incorporated
IE
ultimate parent company
accounts
Small Company
last accounts submitted
June 2023
previous names
N/A
accountant
-
auditor
-
address
unit 4, garden city shopping centre, ashbourne co meath, ashbourne meath ireland, 23604
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ashbourne pharmacy limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ASHBOURNE PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|